Advanced Biomed Inc. Common Stock
ADVB · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $11 | $13 | $12 | $4 |
| Gross Profit | -$11 | -$13 | -$12 | -$4 |
| % Margin | – | – | – | – |
| R&D Expenses | $909,771 | $880 | $1,383 | $1,620 |
| G&A Expenses | $2,111,265 | $1,262 | $1,323 | $625 |
| SG&A Expenses | $2,111,265 | $1,262 | $1,323 | $625 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$3,020,953 | $400 | $365 | $130 |
| Operating Expenses | $83 | $2,542 | $3,071 | $2,374 |
| Operating Income | -$94 | -$2,542 | -$3,071 | -$2,374 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | -$7 | -$241 | -$662 | -$1,653 |
| Pre-Tax Income | -$102 | -$2,782 | -$3,733 | -$4,028 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$102 | -$2,782 | -$3,733 | -$4,028 |
| % Margin | – | – | – | – |
| EPS | -0.005 | -0.14 | -0.19 | -0.28 |
| % Growth | 96.6% | 26.3% | 32.1% | – |
| EPS Diluted | -0.005 | -0.14 | -0.19 | -0.28 |
| Weighted Avg Shares Out | 21,640 | 20,000 | 19,935 | 14,183 |
| Weighted Avg Shares Out Dil | 21,640 | 20,000 | 19,936 | 14,184 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $53 | $21 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $11 | $400 | $365 | $127 |
| EBITDA | -$91 | -$2,142 | -$2,706 | -$2,244 |
| % Margin | – | – | – | – |